| Attribute |
Value |
| 52 Week Change |
-0.0654366 |
| Address1 |
63 Second Avenue |
| All Time High |
118.01 |
| All Time Low |
1.54 |
| Ask |
109.9 |
| Ask Size |
2 |
| Audit Risk |
8 |
| Average Analyst Rating |
2.3 - Buy |
| Average Daily Volume10 Day |
261,260 |
| Average Daily Volume3 Month |
325,223 |
| Average Volume |
325,223 |
| Average Volume10Days |
261,260 |
| Beta |
0.468 |
| Bid |
88.97 |
| Bid Size |
1 |
| Board Risk |
9 |
| Book Value |
18.384 |
| City |
Burlington |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
5 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
81.55 |
| Current Ratio |
16.312 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
83.85 |
| Day Low |
81.29 |
| Debt To Equity |
45.262 |
| Display Name |
LeMaitre Vascular |
| Dividend Date |
1,788,393,600 |
| Dividend Yield |
1.23 |
| Earnings Call Timestamp End |
1,793,829,600 |
| Earnings Call Timestamp Start |
1,793,829,600 |
| Earnings Growth |
0.226 |
| Earnings Quarterly Growth |
0.237 |
| Earnings Timestamp |
1,793,822,400 |
| Earnings Timestamp End |
1,793,822,400 |
| Earnings Timestamp Start |
1,793,822,400 |
| Ebitda |
83,021,000 |
| Ebitda Margins |
0.31635 |
| Enterprise To Ebitda |
20.224 |
| Enterprise To Revenue |
6.398 |
| Enterprise Value |
1,679,001,856 |
| Eps Current Year |
2.87875 |
| Eps Forward |
3.17875 |
| Eps Trailing Twelve Months |
2.85 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,787,184,000 |
| Exchange |
NGM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
781 221 2223 |
| Fifty Day Average |
81.2978 |
| Fifty Day Average Change |
0.2522049 |
| Fifty Day Average Change Percent |
0.0031022353 |
| Fifty Two Week Change Percent |
-6.54366 |
| Fifty Two Week High |
118.01 |
| Fifty Two Week High Change |
-36.46 |
| Fifty Two Week High Change Percent |
-0.30895686 |
| Fifty Two Week Low |
78.22 |
| Fifty Two Week Low Change |
3.3300018 |
| Fifty Two Week Low Change Percent |
0.042572256 |
| Fifty Two Week Range |
78.22 - 118.01 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,161,264,600,000 |
| Five Year Avg Dividend Yield |
0.88 |
| Float Shares |
21,295,166 |
| Forward Eps |
3.17875 |
| Forward P E |
25.65474 |
| Free Cashflow |
49,263,624 |
| Full Exchange Name |
NasdaqGM |
| Full Time Employees |
646 |
| Fullday Change |
0.0 |
| Fullday Change Percent |
0.0 |
| Fullday Price |
81.55 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.71867996 |
| Gross Profits |
188,604,992 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.06521 |
| Held Percent Institutions |
1.04316 |
| Implied Shares Outstanding |
22,869,257 |
| Industry |
Medical Instruments & Supplies |
| Industry Disp |
Medical Instruments & Supplies |
| Industry Key |
medical-instruments-supplies |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,787,184,000 |
| Last Dividend Value |
0.25 |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. |
| Long Name |
LeMaitre Vascular, Inc. |
| Market |
us_market |
| Market Cap |
1,864,987,904 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_2567538 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
65,673,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
1,842,118,651 |
| Number Of Analyst Opinions |
7 |
| Open |
83.64 |
| Operating Cashflow |
82,979,000 |
| Operating Margins |
0.28983 |
| Overall Risk |
8 |
| Payout Ratio |
0.3158 |
| Peg Ratio |
2.2 |
| Phone |
781 221 2266 |
| Pre Market Change |
0.0 |
| Pre Market Change Percent |
0.0 |
| Pre Market Price |
81.55 |
| Pre Market Time |
1,791,975,935 |
| Previous Close |
82.91 |
| Price Eps Current Year |
28.328268 |
| Price Hint |
2 |
| Price To Book |
4.4359226 |
| Price To Sales Trailing12 Months |
7.106557 |
| Profit Margins |
0.25024998 |
| Quick Ratio |
13.761 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.25 |
| Region |
US |
| Regular Market Change |
-1.36 |
| Regular Market Change Percent |
-1.64033 |
| Regular Market Day High |
83.85 |
| Regular Market Day Low |
81.29 |
| Regular Market Day Range |
81.29 - 83.85 |
| Regular Market Open |
83.64 |
| Regular Market Previous Close |
82.91 |
| Regular Market Price |
81.55 |
| Regular Market Time |
1,791,921,601 |
| Regular Market Volume |
247,755 |
| Return On Assets |
0.07441 |
| Return On Equity |
0.16774 |
| Revenue Growth |
0.096 |
| Revenue Per Share |
11.532 |
| Sand P52 Week Change |
0.17004645 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
7 |
| Shares Outstanding |
22,869,257 |
| Shares Percent Shares Out |
0.076 |
| Shares Short |
1,738,967 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
1,521,649 |
| Short Name |
LeMaitre Vascular, Inc. |
| Short Percent Of Float |
0.0956 |
| Short Ratio |
6.58 |
| Source Interval |
15 |
| State |
MA |
| Symbol |
LMAT |
| Target High Price |
132.0 |
| Target Low Price |
81.0 |
| Target Mean Price |
107.0 |
| Target Median Price |
100.0 |
| Total Cash |
376,240,000 |
| Total Cash Per Share |
16.452 |
| Total Debt |
190,254,000 |
| Total Revenue |
262,432,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.9 |
| Trailing Annual Dividend Yield |
0.010855143 |
| Trailing Eps |
2.85 |
| Trailing P E |
28.614037 |
| Trailing Peg Ratio |
2.131 |
| Triggerable |
1 |
| Two Hundred Day Average |
94.4667 |
| Two Hundred Day Average Change |
-12.916695 |
| Two Hundred Day Average Change Percent |
-0.13673279 |
| Type Disp |
Equity |
| Volume |
247,755 |
| Website |
https://www.lemaitre.com |
| Zip |
1,803 |